- Home
- DMAC vs KRMD Comparison
DMAC vs KRMD Comparison
Compare DMAC & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- KRMD
- Stock Information
- Founded
- DMAC 2000
- KRMD 1980
- Country
- DMAC United States
- KRMD United States
- Employees
- DMAC N/A
- KRMD N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- DMAC Health Care
- KRMD Health Care
- Exchange
- DMAC Nasdaq
- KRMD Nasdaq
- Market Cap
- DMAC 123.8M
- KRMD 111.9M
- IPO Year
- DMAC N/A
- KRMD N/A
- Fundamental
- Price
- DMAC $4.03
- KRMD $2.46
- Analyst Decision
- DMAC Strong Buy
- KRMD Strong Buy
- Analyst Count
- DMAC 2
- KRMD 5
- Target Price
- DMAC $7.00
- KRMD $3.70
- AVG Volume (30 Days)
- DMAC 34.9K
- KRMD 52.1K
- Earning Date
- DMAC 08-07-2024
- KRMD 08-07-2024
- Dividend Yield
- DMAC N/A
- KRMD N/A
- EPS Growth
- DMAC N/A
- KRMD N/A
- EPS
- DMAC N/A
- KRMD N/A
- Revenue
- DMAC N/A
- KRMD $30,817,017.00
- Revenue This Year
- DMAC N/A
- KRMD $15.46
- Revenue Next Year
- DMAC N/A
- KRMD $17.47
- P/E Ratio
- DMAC N/A
- KRMD N/A
- Revenue Growth
- DMAC N/A
- KRMD 4.70
- 52 Week Low
- DMAC $1.94
- KRMD $1.98
- 52 Week High
- DMAC $4.07
- KRMD $3.12
- Technical
- Relative Strength Index (RSI)
- DMAC 62.41
- KRMD 54.63
- Support Level
- DMAC $3.76
- KRMD $2.35
- Resistance Level
- DMAC $4.01
- KRMD $2.54
- Average True Range (ATR)
- DMAC 0.17
- KRMD 0.12
- MACD
- DMAC -0.01
- KRMD 0.02
- Stochastic Oscillator
- DMAC 92.98
- KRMD 76.81
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).